To investigate possible mechanisms whereby miR-320a status might affect mesothelioma tumorigenesis, we searched for predicted targets and identified PDL1, which endows cancer cells the ability to evade the host-antitumoral immune response. This evidence concerns the gene CD274 and cancer.